NCT03096249 is a Phase 1, PHASE2 clinical trial of Oxytocin in Oxytocin, sponsored by KU Leuven.

Who is sponsoring NCT03096249?

NCT03096249 is sponsored by KU Leuven.

What drugs are being tested in NCT03096249?

Interventions in NCT03096249: Oxytocin, Placebo.

Is NCT03096249 still recruiting?

NCT03096249 is currently completed. Last updated 22 July 2022.

Last reviewed 2022-07-22 · How we verify

NCT03096249

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Influence of Oxytocin on Socio-communicative Sensitivity

Completed Phase 1, PHASE2 Last updated 22 July 2022

What this trial tests

Phase 1, PHASE2 trial testing Oxytocin in Oxytocin in 31 participants. Completed in 30 July 2017.

Timeline

21 November 2016

Primary endpoint
30 May 2017

30 July 2017

Quick facts

Lead sponsor	KU Leuven
Phase	Phase 1, PHASE2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	basic science
Enrollment	31
Start date	21 November 2016
Primary completion	30 May 2017
Estimated completion	30 July 2017
Sites	1 location across Belgium

Drugs / interventions tested

Oxytocin (OXYTOCIN) — full drug profile →
Placebo

Conditions studied

Oxytocin — all drugs for Oxytocin →

Sponsor

KU Leuven — full company profile →

Who can join

Adults 18 to 30, male only, with Oxytocin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Oxytocin (OT) is a neuropeptide that acts as a neurotransmitter and neuromodulator in the brain. Previous studies have shown that intranasal administration of OT improves social cognition and behavior (e.g. emotion recognition). In the current study, we want to gain more insight into the underlying mechanisms by which OT influences emotion recognition. More specifically, we will investigate whether intranasal administration of OT enhances the salience of social (compared to non-social) information and whether it increases the neural sensitivity for subtle socio-emotional cues, by recording scalp electroencephalography (EEG) during Fast Periodic Visual Stimulation (FPVS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Oxytocin

Trials testing the same drug.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07188207 — Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section · NA · not yet recruiting
NCT06968481 — Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage · Phase 2 · not yet recruiting
NCT07265180 — Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison · NA · recruiting
NCT07119398 — Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM · Phase 4 · recruiting

Other recruiting trials for Oxytocin

Currently open trials in the same condition.

NCT07351799 — Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU · NA · recruiting
NCT04551482 — Oxytocin for Weight Loss in Adolescents · Phase 2 · recruiting

Other KU Leuven trials

Trials by the same sponsor.

NCT07508696 — Cerebellar Research in Ultrasound Stimulation · NA · not yet recruiting
NCT07476716 — Peer-modeled Intervention · NA · not yet recruiting
NCT07534384 — Automated CPET Interpretation: International Validation Study · not yet recruiting
NCT07419555 — Belgian Lung Function Study · recruiting
NCT07295600 — Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism i · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03096249 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by KU Leuven
Last refreshed: 22 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03096249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing